alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### National Institutes of Health

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

*Name of Committee:*                        National Institute of Diabetes and Digestive and Kidney Diseases Special Emphasis Panel; Team Science (R24) in Diabetes, Endocrinology and Metabolic Diseases.                    

*Date:*                        June 7, 2010.                    

*Time:*                        1:30 p.m. to 4:30 p.m.                    

*Agenda:*                        To review and evaluate grant applications.                    

*Place:*                        National Institutes of Health, Two Democracy Plaza, 6707 Democracy Boulevard, Bethesda, MD 20892. (Telephone Conference Call)                    

*Contact Person:*                        Thomas A. Tatham, PhD, Scientific Review Officer, Review Branch, DEA, NIDDK, National Institutes of Health, Room 760, 6707 Democracy Boulevard, Bethesda, MD 20892-5452, (301) 594-3993,                         *tathamt@mail.nih.gov.*

(Catalogue of Federal Domestic Assistance Program Nos. 93.847, Diabetes, Endocrinology and Metabolic Research; 93.848, Digestive Diseases and Nutrition Research; 93.849, Kidney Diseases, Urology and Hematology Research, National Institutes of Health, HHS)

Dated: May 10, 2010.

Jennifer Spaeth,

Director, Office of Federal Advisory Committee Policy.

[FR Doc. 2010-11593 Filed 5-13-10; 8:45 am]

BILLING CODE 4140-01-P
<PAGE>

                                                                    EXHIBIT 32.2

               CERTIFICATE PURSUANT TO SECTION 1350 OF CHAPTER 63
                          OF TITLE 18 OF THE U.S. CODE

      I, Brian J. Hayden, the Vice President-Finance of Bone Care International,
Inc. (the "Company"), certify that (i) the Annual Report on Form 10-K of the
Company for the fiscal year ended June 30, 2004 (the "Form 10-K") fully complies
with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act
of 1934 and (ii) the information contained in the Form 10-K fairly presents, in
all material respects, the financial condition and results of operations of the
Company.

                                /S/  BRIAN J. HAYDEN
                                ------------------------------------------------
                                Brian J. Hayden
                                September 10, 2004

                                       63
II

106TH CONGRESS

2D SESSION S. 2021

To prohibit high school and college sports gambling in all States including

States where such gambling was permitted prior to 1991.

IN THE SENATE OF THE UNITED STATES

FEBRUARY 1, 2000

Mr. BROWNBACK (for himself, Mr. LEAHY, Mr. COCHRAN, Mr. JEFFORDS,

Mr. HELMS, Mr. DURBIN, Mr. LUGAR, Mr. EDWARDS, Mr. VOINOVICH,

Mr. MCCAIN, and Mrs. FEINSTEIN) introduced the following bill; which

was read twice and referred to the Committee on the Judiciary

A BILL

To prohibit high school and college sports gambling in all

States including States where such gambling was permitted prior to 1991.

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled,

3 SECTION 1. SHORT TITLE.

4 This Act may be cited as the ‘‘High School and Col5 lege Sports Gambling Prohibition Act’’.

6 SEC. 2. PROHIBITION.

7 Section 3704 of title 28, United States Code, is

8 amended—
2

•S 2021 IS

1 (1) in subsection (a), by striking ‘‘Section’’ and

2 inserting ‘‘Except as provided in subsection (c), sec3 tion’’; and

4 (2) by adding at the end the following:

5 ‘‘(c)(1) Section 3702 shall apply to a lottery, sweep6 stakes or other betting, gambling, or wagering scheme

7 based, directly or indirectly, on—

8 ‘‘(A)(i) one or more competitive games in which

9 high school or college athletes participate; or

10 ‘‘(ii) one or more performances of high school

11 or college athletes in competitive games; or

12 ‘‘(B) one or more competitive games at the

13 Summer or Winter Olympics.

14 ‘‘(2) In this section—

15 ‘‘(A) the term ‘high school’ has the meaning

16 given the term ‘secondary school’ in section 14102

17 of the Elementary and Secondary Education Act of

18 1965; and

19 ‘‘(B) the term ‘college’ has the meaning given

20 the term ‘institution of higher education’ in section

21 101 of the Higher Education Act of 1965.’’.
3

•S 2021 IS

1 SEC. 3. EFFECTIVE DATE.

2 The amendments made by section 2 shall take effect

3 on the date that is 30 days after the date of enactment

4 of this Act.

Æ
EXHIBIT 10.6

Pinnacle Bankshares Corporation

Base Salaries of Executive Officers of the Registrant

As of March 23, 2007, the following are the base salaries (on an annual basis) of the executive officers of Pinnacle Bankshares Corporation:



|                                                 |  |   |        
|------------------------------------------------ |  | - | -------
|Robert H. Gilliam Jr.                            |  | $ | 185,000
|President and Chief Executive Officer            |  |   |        
|                                                 | 
|Carroll E. Shelton                               |  | $ | 103,560
|Senior Vice President                            |  |   |        
|                                                 | 
|Bryan M. Lemley                                  |  | $ | 93,720 
|Secretary, Treasurer and Chief Financial Officer |  |   |
<TABLE> <S> <C>


<ARTICLE>                     5

<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                              JUN-30-2000
<PERIOD-START>                                 JUL-01-1999
<PERIOD-END>                                   SEP-30-1999
<CASH>                                               21988
<SECURITIES>                                             0
<RECEIVABLES>                                            0
<ALLOWANCES>                                             0
<INVENTORY>                                              0
<CURRENT-ASSETS>                                     21998
<PP&E>                                              120878
<DEPRECIATION>                                        9339
<TOTAL-ASSETS>                                      502410
<CURRENT-LIABILITIES>                               155812
<BONDS>                                                  0
<PREFERRED-MANDATORY>                                    0
<PREFERRED>                                              0
<COMMON>                                             76518
<OTHER-SE>                                          270080
<TOTAL-LIABILITY-AND-EQUITY>                        502410
<SALES>                                               1387
<TOTAL-REVENUES>                                       1387
<CGS>                                                    0
<TOTAL-COSTS>                                            0
<OTHER-EXPENSES>                                    130188
<LOSS-PROVISION>                                         0
<INTEREST-EXPENSE>                                       0
<INCOME-PRETAX>                                     128821
<INCOME-TAX>                                             0
<INCOME-CONTINUING>                                      0
<DISCONTINUED>                                           0
<EXTRAORDINARY>                                          0
<CHANGES>                                                0
<NET-INCOME>                                       (128821)
<EPS-BASIC>                                            0
<EPS-DILUTED>                                            0



</TABLE>
Exhibit 4.1


         


        CERTIFICATE OF AMENDMENT


         


        OF THE


         


        CERTIFICATE OF INCORPORATION


         


        OF


         


        TII NETWORK TECHNOLOGIES, INC.


         


        It is hereby certified that:


         


        1.         The name of the corporation (hereinafter called the “Corporation”) is TII NETWORK TECHNOLOGIES, INC.


        2.         The Certificate of Incorporation of the Corporation is hereby amended by striking out Article 1 thereof and by substituting in lieu of said Article the following new Article:


        
            	
                         

                    	
                        “1:

                    	
                        The name of the corporation is: Tii Network Technologies, Inc.”

                    


        


        3.         The amendment of the Certificate of Incorporation herein certified has been duly adopted in accordance with the provisions of Section 242 of the General Corporation Law of the State of Delaware.


        4.         The effective time of the amendment herein certified shall be 12:01 a.m. on June 1, 2009.


         


        Signed on May 15, 2009.


         


        
            	
                         

                    	
                        /s/ Kenneth A. Paladino

                    


        


        Kenneth A. Paladino,


        President
EXHIBIT 10.42

                                                 CHUCK MACHE COMMUNICATIONS

                       COACHING AND CONSULTING AGREEMENT

GOALS:  1) Executive Coaching to CEO on reaching 08 stated goals 2) Strategic
Sales & Marketing Consulting on achieving revenue goals.  3) Executive
Coaching to Senior Vice President - Sales & Marketing.

COMPANY:                       American TonerServ Corp.
                               420 Aviation Blvd.  Suite 103
                               Santa Rosa, CA  95403

CONTACT:                       Daniel J. Brinker, President/CEO

TERMS:
                               *  Begins January 1st , 2008
                               *  Ends December 31st, 2008
                               *  $5,000 per month
                               *  Payment schedule:
                                  *  Due on the 15th  of each month
                                  *  First payment is due January 15th, 2008
                               *  Pre-approved reimbursement for business
                                    expenses:
                                  *  Air, transportation, hotel, business
                                       entertainment

Contract cancelable by either party on a quarterly basis

Please make checks payable to: Chuck Mache Communications, Inc.
                               1004 Slate Drive
                               Santa Rosa, CA  95405
                               Phone:  707-538-3270

Please sign below and fax back to Chuck Mache at 707-538-5189.  Thank you


                              /s/ Daniel J. Brinker
                              Name

                              President and CEO
                              Title

                              1-22-08
                              Date
**Exhibit 23.1**
**CONSENT OF INDEPENDENT AUDITORS**
We consent to the incorporation byreference in the Registration Statements on Form S-3(No. 333-89616, No. 333-100857, No. 333-104271,No. 333-107151 and No. 333-110629) and on Form S-8(No. 333-39592, No. 333-42616, No. 333-47250,No. 333-84825, No. 333-88418, No. 333-88420,No. 333-90795 and No. 333-110516) of WebMD Corporation ofour report dated February 27, 2004 (except for Note 22, asto which the date is March 4, 2004), with respect to theconsolidated financial statements of WebMD Corporation included inthis Annual Report (Form 10-K) for the year endedDecember 31, 2003.
Our audits also included the financialstatement schedule of WebMD Corporation listed in Item 15(a).This schedule is the responsibility of the Company’s management.Our responsibility is to express an opinion based on our audits. Inour opinion, the financial statement schedule referred to above, whenconsidered in relation to the basic financial statements taken as awhole, presents fairly in all material respects the information setforth therein.
/s/ Ernst & Young LLP
MetroPark, New JerseyMarch 12, 2004
EX-4.8






Exhibit 4.8






			
	 	 	 
	
	 	






			
	 	 	 
	Clay Brendish	 	 
	c/o BT Centre	 	 
	81 Newgate St	 	 
	London	 	 
	EC1A 7AJ
	 	30 July 2008






Dear Clay,



I am writing to confirm that the
Board has agreed to extend your appointment for three years from 1 September 2008. Your
appointment will continue in all other aspects on the terms set out in your letter of
appointment dated 4 July 2002 including, in particular, that either you or the Board may give
the other at least three months’ written notice to terminate the appointment at any time.



Please sign the attached copy of this letter to confirm your acceptance of this extension on
the above terms and return the copy to me.




	 	 	 
	Yours sincerely
	 	 
	 
	/s/ Andrew J. Parker
 


	 	 
	ANDREW J. PARKER
	 	 







			
	To:	 	Andrew Parker

Company Secretary





I accept this extension of my appointment on the above terms.




	 	 	 	 	 
	/s/ Clay Brendish

	 	 	 	1 August 2008
	 

	 	 	 	 
	Clay Brendish

	 	 	 	Date







	 	 	 	 	 	 	 	 	 
	Andrew J Parker
	 	 	 	 	 	 	 	 
	Company Secretary
	 	 	 	 	 	 	 	 
	BT Group
	 	 	 	 	 	 	 	 
	BT Centre

81 Newgate Street

London EC1A 7AJ

United Kingdom


	 	tel

fax

mob

e-mail
	 	+44 (0)20 7356 5237

+44 (0)20 7356 6135

+44 (0)7802 773635

andrew.j.parker@bt.com

	 	
	 	BT Group plc

Registered Office:

81 Newgate Street, London EC1A 7AJ

Registered in England and Wales no. 4190816


www.bt.com
II

106TH CONGRESS

1ST SESSION S. 228

For the relief of Susan Rebola Cardenas.

IN THE SENATE OF THE UNITED STATES

JANUARY 19, 1999

Mr. INOUYE introduced the following bill; which was read twice and referred

to the Committee on the Judiciary

A BILL

For the relief of Susan Rebola Cardenas.

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled,

3 SECTION 1. PERMANENT RESIDENCE.

4 Notwithstanding any other provision of law, for pur5 poses of the Immigration and Nationality Act (8 U.S.C.

6 1101 et seq.), Susan Rebola Cardenas shall be held and

7 considered to have been lawfully admitted to the United

8 States for permanent residence as of the date of the enact9 ment of this Act upon payment of the required visa fee.

10 SEC. 2. REDUCTION OF NUMBER OF AVAILABLE VISAS.

11 Upon the granting of permanent residence to Susan

12 Rebola Cardenas as provided in this Act, the Secretary
2

•S 228 IS

1 of State shall instruct the proper officer to reduce by one

2 number during the current fiscal year the total number

3 of immigrant visas available to natives of the country of

4 the alien’s birth under section 203(a) of the Immigration

5 and Nationality Act (8 U.S.C. 1153(a)).

Æ
Exhibit 31.1
 CERTIFICATION
  1.
    
    I have reviewed this Quarterly Report on Form 10-Q of First Franklin Corporation;2.
    
    Based on my knowledge, this report does not contain any untrue statement of a material fact
or omit to state a material fact necessary to make the statements made, in light of the
circumstances under which such statements were made, not misleading with respect to the period
covered by this report;3.
    
    Based on my knowledge, the financial statements, and other financial information included in
this report, fairly present in all material respects the financial condition, results of
operations and cash flows of the registrant as of, and for, the periods presented in this
report;4
    
    The registrants other certifying officer(s) and I are responsible for establishing and
maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and
15d-15(e)) for the registrant and have:
     5.
    
    The registrants other certifying officer(s) and I have disclosed, based on our most recent
evaluation of internal control over financial reporting, to the registrants auditors and the
audit committee of the registrants board of directors (or persons performing the equivalent
functions):
   Date: May 14, 2008
    /s/ Thomas H. SiemersThomas H. SiemersPresident and Chief Executive Officer
<PAGE>

                                                                   Exhibit 10.34
                                                                   -------------
                                AMENDMENT NO. 4
                                ---------------
                                      TO
                                      --
                            KIRIN-AMGEN, INC./AMGEN
                            -----------------------
                       G-CSF EUROPEAN LICENSE AGREEMENT
                       --------------------------------

                   THIS AMENDMENT NO. 4 ("Amendment No. 4") TO THAT CERTAIN
   KIRIN-AMGEN, INC./AMGEN G-CSF EUROPEAN LICENSE AGREEMENT ("License
   Agreement"), is made and entered into this 29/TH/ day of December, 1989, by
   and between AMGEN INC., a Delaware corporation ("Amgen") and KIRIN-AMGEN,
   INC., a California corporation ("Corporation").

                                R E C I T A L S
                                - - - - - - - -

                   A. Amgen and Corporation have previously executed that
   certain License Agreement regarding G-CSF and Amendment Nos. 1, 2 and 3.

                   B.   The parties desire to incorporate certain changes into
   the License Agreement pursuant to this Amendment No. 4.

                   NOW, THEREFORE, it is agreed as follows:

   1.              Article II, Section 2.03(d) and (e) at page 5 of the License
   Agreement are hereby deleted and the following substituted in lieu thereof:

                   "(d)  $3,000,000 (U.S.) -- Filing of a Product Licensing
                         Application in the United States."

   2.              Except to the extent as provided herein, the provisions of
   the License Agreement, as amended, are hereby ratified and confirmed in all
   respects.

                   IN WITNESS WHEREOF, the undersigned have caused this
   Amendment No. 4 to be executed as of the first day written above.

                                      AMGEN INC., a Delaware
                                      corporation

                                      By   /s/ Gordon M. Binder
                                           ------------------------------
                                           Gordon M. Binder, Chief
                                           Executive Officer

                                                                      "Amgen"


                                      KIRIN-AMGEN, INC.,
                                      a California corporation

                                      By   /s/ Y. Yamamoto
                                           ------------------------------
                                           Yashushi Yamamoto, Chairman

                                                                   "Corporation"
Fourth Court of Appeals

San Antonio, Texas

January 7, 2020

No. 04-19-00755-CR

Ernest R. CEPEDA,

Appellant

v.

The STATE of Texas,

Appellee

From the 144th Judicial District Court, Bexar County, Texas

Trial Court No. 2019CR7864

Honorable Ray Olivarri, Judge Presiding

O R D E R

A Trial Court’s Certification of Defendant’s Right of Appeal has been filed in this appeal 

in which the trial court judge certifies that the underlying criminal case “is a plea-bargain case, 

and the defendant has NO right of appeal.” It is therefore ORDERED that the trial court clerk 

file an electronic clerk’s record within ten days from the date of this order containing the 

following documents:

1. All pre-trial orders and the related pre-trial motions;

2. The Court Admonishments, the Waiver, Consent to Stipulation of Testimony and 

Stipulations, and all other documents relating to the defendant’s plea bargain;

3. The judgment;

4. All post-judgment motions and orders;

5. The notice of appeal;

6. The Trial Court’s Certification of Defendant’s Right of Appeal; and

7. The criminal docket sheet.
All other appellate deadlines are suspended pending further order of this court. The clerk 

of this court is ORDERED to send a copy of this order to the attorneys of record, the trial court 

clerk, and the court reporter(s) responsible for preparing the reporter’s record in this appeal.

_________________________________

Liza A. Rodriguez, Justice

IN WITNESS WHEREOF, I have hereunto set my hand and affixed the seal of the said 

court on this 7th day of January, 2020.

___________________________________

MICHAEL A. CRUZ,

Clerk of Court
<PAGE>
                                                                    EXHIBIT 99.1


                            CERTIFICATION PURSUANT TO
                             18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002


         In connection with the Quarterly Report of First Franklin Corporation
(the "Company") on Form 10-Q for the period ending June 30, 2002 as filed with
the Securities and Exchange Commission on the date hereof (the "Report"), I,
Thomas H. Siemers, the President and Chief Executive Officer of the Company,
certify, pursuant to 18 U.S.C. ss. 1350, as adopted pursuant to ss. 906 of the
Sarbanes-Oxley Act of 2002, that:

         (1) The Report fully complies with the requirements of section 13(a) or
15(d) of the Securities Exchange Act of 1934; and

         (2) The information contained in the Report fairly presents, in all
material respects, the financial condition and result of operations of the
Company.




/s/ Thomas H. Siemers
------------------------------------
Thomas H. Siemers
President and Chief Executive Officer
August 13, 2002